Sign in
  • Home
  • News Bytes
  • Lead Story
  • Editor’s Zone
  • Industry Reports
  • Events
  • Expert Column
  • Policy
  • Startup Tracker
  • Face to Face
  • Chat with BioVoice
  • BioVoice eMag
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Thursday, May 7, 2026
  • Subscribe
  • SUBSCRIBE
  • Write to Us
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
BioVoice BioVoiceNews
wellness India Expo
BioVoice BioVoice
  • Home
  • News Bytes
    • Academia

      Biocon Foundation, in partnership with BeST Cluster and NCBS, onboards first…

      Biotech

      Bayer to offer Eylea 2mg to treat retinal diseases at lower…

      Biosupplier

      Agilent launches a new customer experience center in Mumbai

      Health

      Cardiology experts emphasize early diagnosis amid rising incidence of Bradycardia

      Health

      4baseCare signs MoU with Maharashtra govt to establish Centre of Excellence…

  • Lead Story
    • BioPharma

      Emcure Pharma reduces Poviztra® starting dose price by 55% at Rs…

      Biotech

      India’s bioeconomy set to hit $300B as patent cliff fuels innovation…

      BioPharma

      Biologics, mRNA and Bio Foundries to set the course for pharma’s…

      Diagnostics

      Yoda Diagnostics hosts ‘Yoda Early Mind Summit’ in New Delhi

      Biovoice Shreehas Tambe
      People

      Shreehas Tambe appointed CEO & MD of Biocon Limited, effective April…

  • Editor’s Zone
    • Health Policy

      A Silent Victory: How Uttar Pradesh reversed its Encephalitis crisis

      Policy

      Beyond Trade: How the EU–India FTA reshapes life-sciences industry

      Editor’s Zone

      Safeguarding Our Healers – India’s Doctors Need Protection

      Editor’s Zone

      Lost in Translation? India’s Biologics R&D Shortfall

      Editor’s Zone

      Bridging Science and Business: The Missing Link in Bioscience Innovation

  • Industry Reports
    • Industry Reports

      India Biotech Outlook 2025: The India Advantage at BIO Boston 2025

      Industry Reports

      Inviting your participation in the upcoming India MedTech Handbook 2024

      Industry Reports

      BioVoice News & ICPA team presents India MedTech Handbook 2023 to…

      MedTech

      India MedTech Handbook 2023 launched at the MedTech Conference in USA

      MedTech

      Releasing Soon: India MedTech Handbook 2023 powered by ICPA & BioVoice…

  • Events
    • video
      Events

      Digitalization has democratized healthcare: Experts at BioVoice News e-Conference

      Events

      BioVoice News to host e-Conference on India’s roadmap to Digital Healthcare…

      video
      Events

      Digitally powered smart labs are the future of biopharma R&D: Experts

      Events

      BioVoice News to organize e-Conference on ‘Digital Laboratories: The Emerging Era…

  • Expert Column
    • Expert Column

      Reimagining preventive medicine through genomics, AI, and early risk detection

      Expert Column

      Early cancer detection begins with getting the first step right

      Expert Column

      Leveraging AI to Strengthen India’s Healthcare System

      Expert Column

      The Rise of HealthTech Startups: Innovations Shaping the Future of Medicine

      Expert Column

      How India is Countering the Growing Challenge of Drug-Resistant TB

  • Policy
    • Health Policy

      TB survivors seek govt clarification on continuity of TB medicines &…

      Events

      BioAsia 2026 positions Telangana as a global TechBio powerhouse

      AgriPolicy

      Budget 2026 charts a technology-led path for Indian agriculture

      Health

      Budget 2026: Healthcare skill development & medical tourism gets due attention

      BioPolicy

      Telangana sets global ambition with next generation life sciences policy 2026–30

  • Startup Tracker
    • Startup Tracker

      IIIT Hyderabad incubated biotech startup BioReform bags global award for ditching…

      Startup Tracker

      Gut Clinic raises $1 million in seed round to build India’s…

      Startup Tracker

      IAN Alpha Fund co-leads ₹70 Cr Series A funding round in…

      Biovoice News invests
      Startup Tracker

      Pandorum Technologies raises US$18 Million in Series B to advance global…

      Startup Tracker

      4baseCare raises Rs 90 Cr in Series B first close led…

  • Face to Face
    • Face to Face

      “Research must be designed for translation, not just for publications”: Dr…

      video
      Face to Face

      Face to Face with BioVoice News: Dr Sajeev Nair, Founder &…

      video
      Face to Face

      FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular…

      video
      Face to Face

      FACE TO FACE: Harish Bisam, Founder & MD, Bisam Pharmaceuticals

      video
      Face to Face

      FACE TO FACE: Dr Pawan Dhar, Executive Director, CVJ Centre for…

  • Chat with BioVoice
    • Chat with BioVoice

      “Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”

      Chat with BioVoice

      “AI’s biggest contribution in cardiac monitoring is its speed and efficiency”

      Chat with BioVoice

      “Our focus is on identifying biological mechanisms that may offer alternative…

      Chat with BioVoice

      “We plan to invest Rs 50 crore in phase for R&D…

      Chat with BioVoice

      “Merck has made significant efforts to strengthen lab solutions and R&D…

  • BioVoice eMag
    • BioVoice eMag

      BioVoice eMagazine November 2025 | Issue 10 | Volume 6

      BioVoice eMag

      BioVoice eMagazine October 2025 | Issue 9 | Volume 6

      BioVoice eMag

      BioVoice eMagazine September 2025 | Issue 8 | Volume 6

      BioVoice eMag

      BioVoice eMagazine July-August 2025 | Issue 7 | Volume 6

      BioVoice eMag

      BioVoice eMagazine June 2025 | Issue 6 | Volume 6

Home Health Hospitals 28 Years of Excellence in Cancer Care: RGCIRC looks to expand its...
  • Health
  • Hospitals
  • News Bytes
  • Top News

28 Years of Excellence in Cancer Care: RGCIRC looks to expand its footprint

A highlight of the celebration was the launch of a refreshed RGCIRC logo, symbolizing the institute's continued evolution and commitment to innovation

By BioVoice Correspondent -
October 1, 2024
0
245
Share on Facebook
Tweet on Twitter
New Delhi: Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), an apex institution for cancer care, plans to expand its reach to other areas of the National Capital Region with its focus on providing high-quality treatment to more people.
This expansion will be carried out strategically, and the institute will also continue to strengthen its philanthropic efforts.
Addressing the RGCIRC family on its 28th anniversary, with the theme “Beyond Excellence,” the leadership reflected on the institute’s nearly three decades of commitment to compassionate care, medical innovation, and cutting-edge research. They highlighted the institute’s significant accomplishments and the strong sense of community that has developed over the years.
Delivering a keynote speech, Rakesh Chopra, Chairman of RGCIRC, who reflected on the RGCIRC’s 28-year legacy stated, “For close to three decades now, RGCIRC has excelled in the fields of cancer research, patient care commitment and its service to the community at large. RGCIRC has been successful because of a strong value system embedded in our DNA, which distinguishes us from other hospitals. We endeavour to serve people and alleviate their pain and suffering too by adopting the most modern ways to fight cancer. And our success at Rohini is a signal from our patients that there is a huge need to serve more. Thus, we are thinking about growth.”
 “Apart from Rohini and Niti Bagh, we are now exploring various other vicinities in NCR for setting up new hospitals. We have already engaged a large firm for this purpose. It will be in a calibrated manner -one at a time ensuring our value system is deeply ingrained in the new hospital before we move to the next. Construction in Niti Bagh is in full swing. We expect that the hospitals will be ready in two years. Following that, we’ll need to start planning for our next location within one to two years.”
Providing a sneak peek into the RGCIRC’s philanthropic work over the years, Mr. DS Negi, CEO, RGCIRC, said, “The very motto of RGCIRC is no one seeking cancer treatment is denied care due to lack of funds and lack of money. With this focus, we spent about Rs 59 crore last year on philanthropic work. The number of donors is increasing every year as they are aware about our philanthropic work.  Over the past decade, we have conducted over 1,20,000 free screenings, identifying 5-6% of participants as being in the pre-cancer stage. This proactive approach has enabled us to save more than 2,000 lives. The number of screenings witnessed a significant leap last year, reaching 24,000. We actively reach out to vulnerable communities, including those residing in slum settlements, offering them free treatment and support.
A highlight of the celebration was the launch of a refreshed RGCIRC logo, symbolizing the institute’s continued evolution and commitment to innovation.
Expressing enthusiasm about the revamped logo, Mr. Rakesh Chopra, stated, “Our current logo was designed 28 years back. During this period, we have crossed many technological and cancer care milestones. Our energy was always focused on cancer care and patient care. We did not focus on brand identity which tended to evolve on its own. But, in today’s time of the internet, smartphones and social media, communication plays a critical role in perception building. Thus, our branding needs to evolve and truly reflect our true identity as well as our core values of ethics, empathy and excellence. As was a private hospital which is about empathy, excellence, and ethics. Our refreshed logo is an outcome of this process. The new logo encapsulates our mission to lead in advancing oncology treatments, research, and patient care. As we unveil this refreshed identity, we remain committed to the human care values that have guided us for almost three decades.”
Dr. Sudhir Kumar Rawal, Medical Director and Chief of GenitoUro-Oncology Services, RGCIRC presented the vote of thanks and acknowledged the invaluable contributions of partners, volunteers, researchers.  “RGCIRC is known all over the world because of the unwavering and untiring contribution of our doctors, nurses and support staff who have always come together to take on new challenges. We must therefore, once again now come together and commit ourselves to extend our performance beyond excellence and remain at the forefront of cancer care innovation in the nation.”
The cultural performances, with a series of activities and awarding successful participants, reinforced the sense of community and collaboration within RGCIRC. As the Institute enters its 29th year, it remains dedicated to serving the community and advancing the field of oncology.

  • TAGS
  • Cancer
  • Delhi
  • Doctors
  • DS Negi
  • Healthcare
  • Hospital
  • innovation
  • Logo
  • New Delhi
  • Oncology
  • Rajiv Gandhi
  • RGCIRC
Previous articleKrsnaa Diagnostics & Medikabazaar seal Rs 300+ crore investment deal to sell advanced imaging technologies
Next articleIIT Madras researchers identify enhanced drug delivery method for eye treatments
BioVoice Correspondent

RELATED ARTICLESMORE FROM AUTHOR

Academia

Biocon Foundation, in partnership with BeST Cluster and NCBS, onboards first BioWISE cohort of Postgraduate Women Students

Biotech

Bayer to offer Eylea 2mg to treat retinal diseases at lower cost in India

Biosupplier

Agilent launches a new customer experience center in Mumbai

Face to Face

Face to Face

“Research must be designed for translation, not just for publications”: Dr...

Rahul Koul - December 18, 2025
336
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem

e-Conference

https://www.youtube.com/watch?v=Nku-bLFGpBI&t=491s

Subscribe Our Newsletter


Chat with BioVoice

Chat with BioVoice

“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”

Rahul Koul - February 26, 2026
168
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans

“AI’s biggest contribution in cardiac monitoring is its speed and efficiency”

January 28, 2026

“Our focus is on identifying biological mechanisms that may offer alternative...

January 19, 2026

R&D

BioPolicy

DBT & BIRAC host webinar on biomanufacturing & biofoundry initiative on...

R&D

New magnetic nanoparticles may help treat cancer

Events

Industry Reports

India Biotech Outlook 2025: The India Advantage at BIO Boston 2025

Events

BioAsia 2025: C4IR Telangana & WEF to spearhead high-level dialogues on...

Events

Countdown begins to BioAsia 2025: A unique platform to showcase startup...

AgriPolicy

NDFC(I) inaugurates 2nd edition of MEWA India 2025

BioVoice
ABOUT US
Welcome to BioVoice News, India’s leading bioscience B2B media network. It serves as credible go-to source for the latest news, insights, interviews and analysis from the dynamic worlds of BioTech, HealthTech and AgriTech. Read More
Contact us: connect@biovoicenews.com
FOLLOW US
  • Terms of Use
  • Privacy
  • Advertise
  • Contact
© Copyright © 2022-2025 BioVoiceNews.com All rights reserved.